[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis]

Ugeskr Laeger. 2004 Oct 4;166(41):3606-9.
[Article in Danish]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Adolescent
  • Adult
  • Aged
  • Antibodies / immunology*
  • Female
  • Humans
  • Interferon-beta / immunology*
  • Interferon-beta / therapeutic use
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • Neutralization Tests
  • Prospective Studies

Substances

  • Adjuvants, Immunologic
  • Antibodies
  • Interferon-beta